Welcome to episode 162 of the Bodybuilding Down Under podcast!

This week, all four of us jumped on for a full-team catch-up before diving into a deep, nuanced discussion around one of the most talked-about topics in the fitness and bodybuilding space right now: GLP-1 agonists.

We break down their rising use, how they work, and the potential implications in the natural bodybuilding scene. Are they performance-enhancing? Are they ethical? And should they be banned?

Here’s what we cover:

🔹 Team updates – Where each of us is currently at with training and life.
🔹 What are GLP-1 agonists? – A brief rundown on their mechanism and original purpose.
🔹 Their role in physique sports – Are they being misused for fat loss in bodybuilding?
🔹 Should they be banned in natural federations? – The moral, practical, and competitive implications.
🔹 WADA's stance – Why they’re on the monitoring list and what that means for the future.
🔹 Our take – Where each of us lands on the issue, and whether their use aligns with the spirit of natural competition.

If you’ve seen GLP-1s popping up in your feed and want an informed, grounded conversation on how they’re being used (and abused) in the sport, this episode is a must-listen.

As always, thanks for tuning in! Be sure to subscribe, leave a five-star review, and share the episode to your IG story so we can repost.

Stay serious about it, and we’ll catch you in the next one!

Instagram Handles:

Bodybuilding Down Under: https://www.instagram.com/bodybuildingdownunder/

Jack: https://www.instagram.com/jack.radfordsmith/

Daniel C: https://www.instagram.com/daniel.chapelle/

Lawrence: https://www.instagram.com/general.muscle/

Daniel Y: https://www.instagram.com/dy.fit/